Huilin Xu

机构：Guangzhou University of Chinese Medicine, Sun Yat-sen University, Wuhan University, The First Affiliated Hospital, Sun Yat-sen University, Fifth Hospital In Wuhan, First Hospital of Jiaxing · ORCID：0000-0002-7675-8374

发表论文 55 篇 · 总被引 757 次 · h-index 15

代表论文

• Bushen-Yizhi formula ameliorates mitochondrial dysfunction and oxidative stress via AMPK/Sirt1 signaling pathway in D-gal-induced aging rats (2023 · Chinese Medicine · 被引 25)
• Inflammatory factors are associated with prognosis of non-small cell lung cancer patients receiving immunotherapy: a meta-analysis (2024 · Scientific Reports · 被引 14)
• Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis (2023 · BMC Cancer · 被引 11)
• Improving central venous catheter care with chlorhexidine gluconate dressings: evidence from a systematic review and Meta-analysis (2024 · Journal of Health Population and Nutrition · 被引 10)
• Assessing the Relationship Between Liver Metastases and the Survival of Patients With Non-Small Cell Lung Cancer After Immune Checkpoint Inhibitors Treatment: A Systematic Review and Meta-Analysis (2023 · Integrative Cancer Therapies · 被引 10)
• Interaction between body mass index and family history of cancer on the risk of female breast cancer (2024 · Scientific Reports · 被引 6)